Patients in New York diagnosed with one of the following severe, debilitating, or life-threatening medical conditions, are afforded legal protection under New York’s medical marijuana law, as per Assembly Bill 6357:
- Positive status for Human Immunodeficiency Virus (HIV) or Acquired Immune Deficiency Syndrome (AIDS)
- Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease)
- Parkinson’s Disease
- Multiple Sclerosis
- Damage to the nervous tissue of the spinal cord with objective neurological indication of intractable Spasticity
- Inflammatory Bowel Disease (IBD)
- Ulcerative Colitis
- Crohn’s Disease
- Chronic Inflammatory Demyelinating Polyneuropathy
- Huntington’s Disease
Effective March 22, 2017 chronic pain has been approved by Health Commissioner, Dr. Howard A. Zucker – any severe debilitating pain that the practitioner determines degrades health and functional capability, that has intolerable side effects, that has lasted for or is expected to last for at least three months, and other modes of therapy that has failed to treat or that cannot be treated by another therapy because it would be harmful.”
- Post-Traumatic Stress Disorder (PTSD) is officially an approved qualifying medical condition – Gov. Cuomo signed Bill S.5629 (Savino)/A.7006 (Gottfied) on Veteran’s Day – November 11th, 2017 to allow emergency access and expedited certification for patients suffering from this condition.
- As of June 2018, a regulatory amendment issued by the NY State Department of Health added opioid use as a qualifying condition. In July 2018, this was expanded and any condition for which an opioid could be prescribed now qualifies for medical marijuana due to emergency regulations issues by the NY State Department of Health.